Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Diabetes Medicines Market Insights, Forecast to 2030

Global Diabetes Medicines Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-03-18

Pages: 166 Pages

Report ld: 2657432

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global Diabetes Medicines market is projected to grow from US$ 109380 million in 2024 to US$ 207020 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period.

Diabetes Medicines Market Size

M= millions and B=billions

Global Diabetes Medicines key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%.
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.

Report Includes
This report presents an overview of global market for Diabetes Medicines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Diabetes Medicines, also provides the sales of main regions and countries. of the upcoming market potential for Diabetes Medicines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetes Medicines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetes Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Diabetes Medicines sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Diabetes Medicines Market Insights, Forecast to 2030
Forecasted Market Size in 2030
US$ 207020 million
CAGR(2024-2030)
11.2%
Market Size Available for Years
2019-2030
Global Diabetes Medicines Companies Covered
Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, United Pharmaceuticals, Ganli Pharmaceutical, Biocon, Conker Pharmaceuticals, Jiangsu Wanbang, Geropharm, Wockhardt, Merck Serono, Novartis
Global Diabetes Medicines Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Medicines Market, Segment by Type
Oral

Injection
Global Diabetes Medicines Market, Segment by Application
Hospital

Retail Pharmacy
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Diabetes Medicines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Diabetes Medicines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Medicines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Table of Contents

 1 Study Coverage
    1.1 Diabetes Medicines Product Introduction
    1.2 Market by Type
        1.2.1 Global Diabetes Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Oral
        1.2.3 Injection
    1.3 Market by Application
        1.3.1 Global Diabetes Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Diabetes Medicines Revenue Estimates and Forecasts 2019-2030
    2.2 Global Diabetes Medicines Revenue by Region
        2.2.1 Global Diabetes Medicines Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Diabetes Medicines Revenue by Region (2019-2024)
        2.2.3 Global Diabetes Medicines Revenue by Region (2025-2030)
        2.2.4 Global Diabetes Medicines Revenue Market Share by Region (2019-2030)
    2.3 Global Diabetes Medicines Sales Estimates and Forecasts 2019-2030
    2.4 Global Diabetes Medicines Sales by Region
        2.4.1 Global Diabetes Medicines Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Diabetes Medicines Sales by Region (2019-2024)
        2.4.3 Global Diabetes Medicines Sales by Region (2025-2030)
        2.4.4 Global Diabetes Medicines Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufacturers
    3.1 Global Diabetes Medicines Sales by Manufacturers
        3.1.1 Global Diabetes Medicines Sales by Manufacturers (2019-2024)
        3.1.2 Global Diabetes Medicines Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetes Medicines in 2023
    3.2 Global Diabetes Medicines Revenue by Manufacturers
        3.2.1 Global Diabetes Medicines Revenue by Manufacturers (2019-2024)
        3.2.2 Global Diabetes Medicines Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Diabetes Medicines Revenue in 2023
    3.3 Global Key Players of Diabetes Medicines, Industry Ranking, 2021 VS 2022
    3.4 Global Diabetes Medicines Sales Price by Manufacturers (2019-2024)
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Diabetes Medicines, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Diabetes Medicines, Product Offered and Application
    3.8 Global Key Manufacturers of Diabetes Medicines, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Diabetes Medicines Sales by Type
        4.1.1 Global Diabetes Medicines Historical Sales by Type (2019-2024)
        4.1.2 Global Diabetes Medicines Forecasted Sales by Type (2025-2030)
        4.1.3 Global Diabetes Medicines Sales Market Share by Type (2019-2030)
    4.2 Global Diabetes Medicines Revenue by Type
        4.2.1 Global Diabetes Medicines Historical Revenue by Type (2019-2024)
        4.2.2 Global Diabetes Medicines Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Diabetes Medicines Revenue Market Share by Type (2019-2030)
    4.3 Global Diabetes Medicines Price by Type
        4.3.1 Global Diabetes Medicines Price by Type (2019-2024)
        4.3.2 Global Diabetes Medicines Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Diabetes Medicines Sales by Application
        5.1.1 Global Diabetes Medicines Historical Sales by Application (2019-2024)
        5.1.2 Global Diabetes Medicines Forecasted Sales by Application (2025-2030)
        5.1.3 Global Diabetes Medicines Sales Market Share by Application (2019-2030)
    5.2 Global Diabetes Medicines Revenue by Application
        5.2.1 Global Diabetes Medicines Historical Revenue by Application (2019-2024)
        5.2.2 Global Diabetes Medicines Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Diabetes Medicines Revenue Market Share by Application (2019-2030)
    5.3 Global Diabetes Medicines Price by Application
        5.3.1 Global Diabetes Medicines Price by Application (2019-2024)
        5.3.2 Global Diabetes Medicines Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Diabetes Medicines Market Size by Type
        6.1.1 US & Canada Diabetes Medicines Sales by Type (2019-2030)
        6.1.2 US & Canada Diabetes Medicines Revenue by Type (2019-2030)
    6.2 US & Canada Diabetes Medicines Market Size by Application
        6.2.1 US & Canada Diabetes Medicines Sales by Application (2019-2030)
        6.2.2 US & Canada Diabetes Medicines Revenue by Application (2019-2030)
    6.3 US & Canada Diabetes Medicines Market Size by Country
        6.3.1 US & Canada Diabetes Medicines Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Diabetes Medicines Revenue by Country (2019-2030)
        6.3.3 US & Canada Diabetes Medicines Sales by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Diabetes Medicines Market Size by Type
        7.1.1 Europe Diabetes Medicines Sales by Type (2019-2030)
        7.1.2 Europe Diabetes Medicines Revenue by Type (2019-2030)
    7.2 Europe Diabetes Medicines Market Size by Application
        7.2.1 Europe Diabetes Medicines Sales by Application (2019-2030)
        7.2.2 Europe Diabetes Medicines Revenue by Application (2019-2030)
    7.3 Europe Diabetes Medicines Market Size by Country
        7.3.1 Europe Diabetes Medicines Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Diabetes Medicines Revenue by Country (2019-2030)
        7.3.3 Europe Diabetes Medicines Sales by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Diabetes Medicines Market Size by Type
        8.1.1 China Diabetes Medicines Sales by Type (2019-2030)
        8.1.2 China Diabetes Medicines Revenue by Type (2019-2030)
    8.2 China Diabetes Medicines Market Size by Application
        8.2.1 China Diabetes Medicines Sales by Application (2019-2030)
        8.2.2 China Diabetes Medicines Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Diabetes Medicines Market Size by Type
        9.1.1 Asia Diabetes Medicines Sales by Type (2019-2030)
        9.1.2 Asia Diabetes Medicines Revenue by Type (2019-2030)
    9.2 Asia Diabetes Medicines Market Size by Application
        9.2.1 Asia Diabetes Medicines Sales by Application (2019-2030)
        9.2.2 Asia Diabetes Medicines Revenue by Application (2019-2030)
    9.3 Asia Diabetes Medicines Market Size by Region
        9.3.1 Asia Diabetes Medicines Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Diabetes Medicines Revenue by Region (2019-2030)
        9.3.3 Asia Diabetes Medicines Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India
        9.3.9 Australia

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Diabetes Medicines Market Size by Type
        10.1.1 Middle East, Africa and Latin America Diabetes Medicines Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Diabetes Medicines Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Diabetes Medicines Market Size by Application
        10.2.1 Middle East, Africa and Latin America Diabetes Medicines Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Diabetes Medicines Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Diabetes Medicines Market Size by Country
        10.3.1 Middle East, Africa and Latin America Diabetes Medicines Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Diabetes Medicines Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Diabetes Medicines Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Corporate Profile
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Company Information
        11.1.2 Novo Nordisk Overview
        11.1.3 Novo Nordisk Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 Novo Nordisk Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novo Nordisk Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Information
        11.2.2 Sanofi Overview
        11.2.3 Sanofi Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 Sanofi Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Recent Developments
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Information
        11.3.2 Eli Lilly Overview
        11.3.3 Eli Lilly Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Eli Lilly Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Eli Lilly Recent Developments
    11.4 Merck
        11.4.1 Merck Company Information
        11.4.2 Merck Overview
        11.4.3 Merck Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 Merck Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Merck Recent Developments
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Information
        11.5.2 AstraZeneca Overview
        11.5.3 AstraZeneca Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 AstraZeneca Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 AstraZeneca Recent Developments
    11.6 bayer
        11.6.1 bayer Company Information
        11.6.2 bayer Overview
        11.6.3 bayer Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 bayer Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 bayer Recent Developments
    11.7 Boehringer Ingelheim
        11.7.1 Boehringer Ingelheim Company Information
        11.7.2 Boehringer Ingelheim Overview
        11.7.3 Boehringer Ingelheim Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.7.4 Boehringer Ingelheim Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Boehringer Ingelheim Recent Developments
    11.8 Johnson & Johnson
        11.8.1 Johnson & Johnson Company Information
        11.8.2 Johnson & Johnson Overview
        11.8.3 Johnson & Johnson Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.8.4 Johnson & Johnson Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Johnson & Johnson Recent Developments
    11.9 Takeda
        11.9.1 Takeda Company Information
        11.9.2 Takeda Overview
        11.9.3 Takeda Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.9.4 Takeda Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Takeda Recent Developments
    11.10 Tonghua Dongbao
        11.10.1 Tonghua Dongbao Company Information
        11.10.2 Tonghua Dongbao Overview
        11.10.3 Tonghua Dongbao Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.10.4 Tonghua Dongbao Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Tonghua Dongbao Recent Developments
    11.11 United Pharmaceuticals
        11.11.1 United Pharmaceuticals Company Information
        11.11.2 United Pharmaceuticals Overview
        11.11.3 United Pharmaceuticals Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.11.4 United Pharmaceuticals Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 United Pharmaceuticals Recent Developments
    11.12 Ganli Pharmaceutical
        11.12.1 Ganli Pharmaceutical Company Information
        11.12.2 Ganli Pharmaceutical Overview
        11.12.3 Ganli Pharmaceutical Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.12.4 Ganli Pharmaceutical Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Ganli Pharmaceutical Recent Developments
    11.13 Biocon
        11.13.1 Biocon Company Information
        11.13.2 Biocon Overview
        11.13.3 Biocon Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.13.4 Biocon Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Biocon Recent Developments
    11.14 Conker Pharmaceuticals
        11.14.1 Conker Pharmaceuticals Company Information
        11.14.2 Conker Pharmaceuticals Overview
        11.14.3 Conker Pharmaceuticals Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.14.4 Conker Pharmaceuticals Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Conker Pharmaceuticals Recent Developments
    11.15 Jiangsu Wanbang
        11.15.1 Jiangsu Wanbang Company Information
        11.15.2 Jiangsu Wanbang Overview
        11.15.3 Jiangsu Wanbang Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.15.4 Jiangsu Wanbang Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Jiangsu Wanbang Recent Developments
    11.16 Geropharm
        11.16.1 Geropharm Company Information
        11.16.2 Geropharm Overview
        11.16.3 Geropharm Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.16.4 Geropharm Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Geropharm Recent Developments
    11.17 Wockhardt
        11.17.1 Wockhardt Company Information
        11.17.2 Wockhardt Overview
        11.17.3 Wockhardt Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.17.4 Wockhardt Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Wockhardt Recent Developments
    11.18 Merck Serono
        11.18.1 Merck Serono Company Information
        11.18.2 Merck Serono Overview
        11.18.3 Merck Serono Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.18.4 Merck Serono Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Merck Serono Recent Developments
    11.19 Novartis
        11.19.1 Novartis Company Information
        11.19.2 Novartis Overview
        11.19.3 Novartis Diabetes Medicines Sales, Price, Revenue and Gross Margin (2019-2024)
        11.19.4 Novartis Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Novartis Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Diabetes Medicines Industry Chain Analysis
    12.2 Diabetes Medicines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Diabetes Medicines Production Mode & Process
    12.4 Diabetes Medicines Sales and Marketing
        12.4.1 Diabetes Medicines Sales Channels
        12.4.2 Diabetes Medicines Distributors
    12.5 Diabetes Medicines Customers

 13 Diabetes Medicines Market Dynamics
    13.1 Diabetes Medicines Industry Trends
    13.2 Diabetes Medicines Market Drivers
    13.3 Diabetes Medicines Market Challenges
    13.4 Diabetes Medicines Market Restraints

 14 Key Findings in the Global Diabetes Medicines Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Diabetes Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Oral
 Table 3. Major Manufacturers of Injection
 Table 4. Global Diabetes Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 5. Global Diabetes Medicines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 6. Global Diabetes Medicines Revenue by Region (2019-2024) & (US$ Million)
 Table 7. Global Diabetes Medicines Revenue by Region (2025-2030) & (US$ Million)
 Table 8. Global Diabetes Medicines Revenue Market Share by Region (2019-2024)
 Table 9. Global Diabetes Medicines Revenue Market Share by Region (2025-2030)
 Table 10. Global Diabetes Medicines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 11. Global Diabetes Medicines Sales by Region (2019-2024) & (K Units)
 Table 12. Global Diabetes Medicines Sales by Region (2025-2030) & (K Units)
 Table 13. Global Diabetes Medicines Sales Market Share by Region (2019-2024)
 Table 14. Global Diabetes Medicines Sales Market Share by Region (2025-2030)
 Table 15. Global Diabetes Medicines Sales by Manufacturers (2019-2024) & (K Units)
 Table 16. Global Diabetes Medicines Sales Share by Manufacturers (2019-2024)
 Table 17. Global Diabetes Medicines Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 18. Global Diabetes Medicines Revenue Market Share by Manufacturers (2019-2024)
 Table 19. Global Key Players of Diabetes Medicines, Industry Ranking, 2021 VS 2022 VS 2023
 Table 20. Diabetes Medicines Price by Manufacturers (2019-2024) & (US$/Unit)
 Table 21. Global Diabetes Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 22. Global Diabetes Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Medicines as of 2023)
 Table 23. Global Key Manufacturers of Diabetes Medicines, Manufacturing Base Distribution and Headquarters
 Table 24. Global Key Manufacturers of Diabetes Medicines, Product Offered and Application
 Table 25. Global Key Manufacturers of Diabetes Medicines, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Diabetes Medicines Sales by Type (2019-2024) & (K Units)
 Table 28. Global Diabetes Medicines Sales by Type (2025-2030) & (K Units)
 Table 29. Global Diabetes Medicines Sales Share by Type (2019-2024)
 Table 30. Global Diabetes Medicines Sales Share by Type (2025-2030)
 Table 31. Global Diabetes Medicines Revenue by Type (2019-2024) & (US$ Million)
 Table 32. Global Diabetes Medicines Revenue by Type (2025-2030) & (US$ Million)
 Table 33. Global Diabetes Medicines Revenue Share by Type (2019-2024)
 Table 34. Global Diabetes Medicines Revenue Share by Type (2025-2030)
 Table 35. Diabetes Medicines Price by Type (2019-2024) & (US$/Unit)
 Table 36. Global Diabetes Medicines Price Forecast by Type (2025-2030) & (US$/Unit)
 Table 37. Global Diabetes Medicines Sales by Application (2019-2024) & (K Units)
 Table 38. Global Diabetes Medicines Sales by Application (2025-2030) & (K Units)
 Table 39. Global Diabetes Medicines Sales Share by Application (2019-2024)
 Table 40. Global Diabetes Medicines Sales Share by Application (2025-2030)
 Table 41. Global Diabetes Medicines Revenue by Application (2019-2024) & (US$ Million)
 Table 42. Global Diabetes Medicines Revenue by Application (2025-2030) & (US$ Million)
 Table 43. Global Diabetes Medicines Revenue Share by Application (2019-2024)
 Table 44. Global Diabetes Medicines Revenue Share by Application (2025-2030)
 Table 45. Diabetes Medicines Price by Application (2019-2024) & (US$/Unit)
 Table 46. Global Diabetes Medicines Price Forecast by Application (2025-2030) & (US$/Unit)
 Table 47. US & Canada Diabetes Medicines Sales by Type (2019-2024) & (K Units)
 Table 48. US & Canada Diabetes Medicines Sales by Type (2025-2030) & (K Units)
 Table 49. US & Canada Diabetes Medicines Revenue by Type (2019-2024) & (US$ Million)
 Table 50. US & Canada Diabetes Medicines Revenue by Type (2025-2030) & (US$ Million)
 Table 51. US & Canada Diabetes Medicines Sales by Application (2019-2024) & (K Units)
 Table 52. US & Canada Diabetes Medicines Sales by Application (2025-2030) & (K Units)
 Table 53. US & Canada Diabetes Medicines Revenue by Application (2019-2024) & (US$ Million)
 Table 54. US & Canada Diabetes Medicines Revenue by Application (2025-2030) & (US$ Million)
 Table 55. US & Canada Diabetes Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 56. US & Canada Diabetes Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 57. US & Canada Diabetes Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 58. US & Canada Diabetes Medicines Sales by Country (2019-2024) & (K Units)
 Table 59. US & Canada Diabetes Medicines Sales by Country (2025-2030) & (K Units)
 Table 60. Europe Diabetes Medicines Sales by Type (2019-2024) & (K Units)
 Table 61. Europe Diabetes Medicines Sales by Type (2025-2030) & (K Units)
 Table 62. Europe Diabetes Medicines Revenue by Type (2019-2024) & (US$ Million)
 Table 63. Europe Diabetes Medicines Revenue by Type (2025-2030) & (US$ Million)
 Table 64. Europe Diabetes Medicines Sales by Application (2019-2024) & (K Units)
 Table 65. Europe Diabetes Medicines Sales by Application (2025-2030) & (K Units)
 Table 66. Europe Diabetes Medicines Revenue by Application (2019-2024) & (US$ Million)
 Table 67. Europe Diabetes Medicines Revenue by Application (2025-2030) & (US$ Million)
 Table 68. Europe Diabetes Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 69. Europe Diabetes Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 70. Europe Diabetes Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 71. Europe Diabetes Medicines Sales by Country (2019-2024) & (K Units)
 Table 72. Europe Diabetes Medicines Sales by Country (2025-2030) & (K Units)
 Table 73. China Diabetes Medicines Sales by Type (2019-2024) & (K Units)
 Table 74. China Diabetes Medicines Sales by Type (2025-2030) & (K Units)
 Table 75. China Diabetes Medicines Revenue by Type (2019-2024) & (US$ Million)
 Table 76. China Diabetes Medicines Revenue by Type (2025-2030) & (US$ Million)
 Table 77. China Diabetes Medicines Sales by Application (2019-2024) & (K Units)
 Table 78. China Diabetes Medicines Sales by Application (2025-2030) & (K Units)
 Table 79. China Diabetes Medicines Revenue by Application (2019-2024) & (US$ Million)
 Table 80. China Diabetes Medicines Revenue by Application (2025-2030) & (US$ Million)
 Table 81. Asia Diabetes Medicines Sales by Type (2019-2024) & (K Units)
 Table 82. Asia Diabetes Medicines Sales by Type (2025-2030) & (K Units)
 Table 83. Asia Diabetes Medicines Revenue by Type (2019-2024) & (US$ Million)
 Table 84. Asia Diabetes Medicines Revenue by Type (2025-2030) & (US$ Million)
 Table 85. Asia Diabetes Medicines Sales by Application (2019-2024) & (K Units)
 Table 86. Asia Diabetes Medicines Sales by Application (2025-2030) & (K Units)
 Table 87. Asia Diabetes Medicines Revenue by Application (2019-2024) & (US$ Million)
 Table 88. Asia Diabetes Medicines Revenue by Application (2025-2030) & (US$ Million)
 Table 89. Asia Diabetes Medicines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 90. Asia Diabetes Medicines Revenue by Region (2019-2024) & (US$ Million)
 Table 91. Asia Diabetes Medicines Revenue by Region (2025-2030) & (US$ Million)
 Table 92. Asia Diabetes Medicines Sales by Region (2019-2024) & (K Units)
 Table 93. Asia Diabetes Medicines Sales by Region (2025-2030) & (K Units)
 Table 94. Middle East, Africa and Latin America Diabetes Medicines Sales by Type (2019-2024) & (K Units)
 Table 95. Middle East, Africa and Latin America Diabetes Medicines Sales by Type (2025-2030) & (K Units)
 Table 96. Middle East, Africa and Latin America Diabetes Medicines Revenue by Type (2019-2024) & (US$ Million)
 Table 97. Middle East, Africa and Latin America Diabetes Medicines Revenue by Type (2025-2030) & (US$ Million)
 Table 98. Middle East, Africa and Latin America Diabetes Medicines Sales by Application (2019-2024) & (K Units)
 Table 99. Middle East, Africa and Latin America Diabetes Medicines Sales by Application (2025-2030) & (K Units)
 Table 100. Middle East, Africa and Latin America Diabetes Medicines Revenue by Application (2019-2024) & (US$ Million)
 Table 101. Middle East, Africa and Latin America Diabetes Medicines Revenue by Application (2025-2030) & (US$ Million)
 Table 102. Middle East, Africa and Latin America Diabetes Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 103. Middle East, Africa and Latin America Diabetes Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 104. Middle East, Africa and Latin America Diabetes Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 105. Middle East, Africa and Latin America Diabetes Medicines Sales by Country (2019-2024) & (K Units)
 Table 106. Middle East, Africa and Latin America Diabetes Medicines Sales by Country (2025-2030) & (K Units)
 Table 107. Novo Nordisk Company Information
 Table 108. Novo Nordisk Description and Major Businesses
 Table 109. Novo Nordisk Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. Novo Nordisk Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 111. Novo Nordisk Recent Developments
 Table 112. Sanofi Company Information
 Table 113. Sanofi Description and Major Businesses
 Table 114. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Sanofi Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. Sanofi Recent Developments
 Table 117. Eli Lilly Company Information
 Table 118. Eli Lilly Description and Major Businesses
 Table 119. Eli Lilly Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Eli Lilly Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. Eli Lilly Recent Developments
 Table 122. Merck Company Information
 Table 123. Merck Description and Major Businesses
 Table 124. Merck Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 125. Merck Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 126. Merck Recent Developments
 Table 127. AstraZeneca Company Information
 Table 128. AstraZeneca Description and Major Businesses
 Table 129. AstraZeneca Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 130. AstraZeneca Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 131. AstraZeneca Recent Developments
 Table 132. bayer Company Information
 Table 133. bayer Description and Major Businesses
 Table 134. bayer Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 135. bayer Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 136. bayer Recent Developments
 Table 137. Boehringer Ingelheim Company Information
 Table 138. Boehringer Ingelheim Description and Major Businesses
 Table 139. Boehringer Ingelheim Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 140. Boehringer Ingelheim Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 141. Boehringer Ingelheim Recent Developments
 Table 142. Johnson & Johnson Company Information
 Table 143. Johnson & Johnson Description and Major Businesses
 Table 144. Johnson & Johnson Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 145. Johnson & Johnson Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 146. Johnson & Johnson Recent Developments
 Table 147. Takeda Company Information
 Table 148. Takeda Description and Major Businesses
 Table 149. Takeda Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 150. Takeda Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 151. Takeda Recent Developments
 Table 152. Tonghua Dongbao Company Information
 Table 153. Tonghua Dongbao Description and Major Businesses
 Table 154. Tonghua Dongbao Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 155. Tonghua Dongbao Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 156. Tonghua Dongbao Recent Developments
 Table 157. United Pharmaceuticals Company Information
 Table 158. United Pharmaceuticals Description and Major Businesses
 Table 159. United Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 160. United Pharmaceuticals Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 161. United Pharmaceuticals Recent Developments
 Table 162. Ganli Pharmaceutical Company Information
 Table 163. Ganli Pharmaceutical Description and Major Businesses
 Table 164. Ganli Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 165. Ganli Pharmaceutical Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 166. Ganli Pharmaceutical Recent Developments
 Table 167. Biocon Company Information
 Table 168. Biocon Description and Major Businesses
 Table 169. Biocon Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 170. Biocon Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 171. Biocon Recent Developments
 Table 172. Conker Pharmaceuticals Company Information
 Table 173. Conker Pharmaceuticals Description and Major Businesses
 Table 174. Conker Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 175. Conker Pharmaceuticals Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 176. Conker Pharmaceuticals Recent Developments
 Table 177. Jiangsu Wanbang Company Information
 Table 178. Jiangsu Wanbang Description and Major Businesses
 Table 179. Jiangsu Wanbang Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 180. Jiangsu Wanbang Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 181. Jiangsu Wanbang Recent Developments
 Table 182. Geropharm Company Information
 Table 183. Geropharm Description and Major Businesses
 Table 184. Geropharm Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 185. Geropharm Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 186. Geropharm Recent Developments
 Table 187. Wockhardt Company Information
 Table 188. Wockhardt Description and Major Businesses
 Table 189. Wockhardt Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 190. Wockhardt Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 191. Wockhardt Recent Developments
 Table 192. Merck Serono Company Information
 Table 193. Merck Serono Description and Major Businesses
 Table 194. Merck Serono Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 195. Merck Serono Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 196. Merck Serono Recent Developments
 Table 197. Novartis Company Information
 Table 198. Novartis Description and Major Businesses
 Table 199. Novartis Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 200. Novartis Diabetes Medicines Product Model Numbers, Pictures, Descriptions and Specifications
 Table 201. Novartis Recent Developments
 Table 202. Key Raw Materials Lists
 Table 203. Raw Materials Key Suppliers Lists
 Table 204. Diabetes Medicines Distributors List
 Table 205. Diabetes Medicines Customers List
 Table 206. Diabetes Medicines Market Trends
 Table 207. Diabetes Medicines Market Drivers
 Table 208. Diabetes Medicines Market Challenges
 Table 209. Diabetes Medicines Market Restraints
 Table 210. Research Programs/Design for This Report
 Table 211. Key Data Information from Secondary Sources
 Table 212. Key Data Information from Primary Sources


List of Figures
 Figure 1. Diabetes Medicines Product Picture
 Figure 2. Global Diabetes Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Diabetes Medicines Market Share by Type: 2023 & 2030
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Diabetes Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 7. Global Diabetes Medicines Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Retail Pharmacy
 Figure 10. Diabetes Medicines Report Years Considered
 Figure 11. Global Diabetes Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 13. Global Diabetes Medicines Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 14. Global Diabetes Medicines Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 15. Global Diabetes Medicines Revenue Market Share by Region (2019-2030)
 Figure 16. Global Diabetes Medicines Sales (2019-2030) & (K Units)
 Figure 17. Global Diabetes Medicines Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 18. Global Diabetes Medicines Sales Market Share by Region (2019-2030)
 Figure 19. US & Canada Diabetes Medicines Sales YoY (2019-2030) & (K Units)
 Figure 20. US & Canada Diabetes Medicines Revenue YoY (2019-2030) & (US$ Million)
 Figure 21. Europe Diabetes Medicines Sales YoY (2019-2030) & (K Units)
 Figure 22. Europe Diabetes Medicines Revenue YoY (2019-2030) & (US$ Million)
 Figure 23. China Diabetes Medicines Sales YoY (2019-2030) & (K Units)
 Figure 24. China Diabetes Medicines Revenue YoY (2019-2030) & (US$ Million)
 Figure 25. Asia (excluding China) Diabetes Medicines Sales YoY (2019-2030) & (K Units)
 Figure 26. Asia (excluding China) Diabetes Medicines Revenue YoY (2019-2030) & (US$ Million)
 Figure 27. Middle East, Africa and Latin America Diabetes Medicines Sales YoY (2019-2030) & (K Units)
 Figure 28. Middle East, Africa and Latin America Diabetes Medicines Revenue YoY (2019-2030) & (US$ Million)
 Figure 29. Global Diabetes Medicines Sales Share by Manufacturers (2023)
 Figure 30. The Diabetes Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 31. Global Diabetes Medicines Revenue Share by Manufacturers (2023)
 Figure 32. The Top 5 and 10 Largest Manufacturers of Diabetes Medicines in the World: Market Share by Diabetes Medicines Revenue in 2023
 Figure 33. Global Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 34. Global Diabetes Medicines Sales Market Share by Type (2019-2030)
 Figure 35. Global Diabetes Medicines Revenue Market Share by Type (2019-2030)
 Figure 36. Global Diabetes Medicines Sales Market Share by Application (2019-2030)
 Figure 37. Global Diabetes Medicines Revenue Market Share by Application (2019-2030)
 Figure 38. US & Canada Diabetes Medicines Sales Market Share by Type (2019-2030)
 Figure 39. US & Canada Diabetes Medicines Revenue Market Share by Type (2019-2030)
 Figure 40. US & Canada Diabetes Medicines Sales Market Share by Application (2019-2030)
 Figure 41. US & Canada Diabetes Medicines Revenue Market Share by Application (2019-2030)
 Figure 42. US & Canada Diabetes Medicines Revenue Share by Country (2019-2030)
 Figure 43. US & Canada Diabetes Medicines Sales Share by Country (2019-2030)
 Figure 44. US Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 45. Canada Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 46. Europe Diabetes Medicines Sales Market Share by Type (2019-2030)
 Figure 47. Europe Diabetes Medicines Revenue Market Share by Type (2019-2030)
 Figure 48. Europe Diabetes Medicines Sales Market Share by Application (2019-2030)
 Figure 49. Europe Diabetes Medicines Revenue Market Share by Application (2019-2030)
 Figure 50. Europe Diabetes Medicines Revenue Share by Country (2019-2030)
 Figure 51. Europe Diabetes Medicines Sales Share by Country (2019-2030)
 Figure 52. Germany Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 53. France Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 54. U.K. Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 55. Italy Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 56. Russia Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 57. China Diabetes Medicines Sales Market Share by Type (2019-2030)
 Figure 58. China Diabetes Medicines Revenue Market Share by Type (2019-2030)
 Figure 59. China Diabetes Medicines Sales Market Share by Application (2019-2030)
 Figure 60. China Diabetes Medicines Revenue Market Share by Application (2019-2030)
 Figure 61. Asia Diabetes Medicines Sales Market Share by Type (2019-2030)
 Figure 62. Asia Diabetes Medicines Revenue Market Share by Type (2019-2030)
 Figure 63. Asia Diabetes Medicines Sales Market Share by Application (2019-2030)
 Figure 64. Asia Diabetes Medicines Revenue Market Share by Application (2019-2030)
 Figure 65. Asia Diabetes Medicines Revenue Share by Region (2019-2030)
 Figure 66. Asia Diabetes Medicines Sales Share by Region (2019-2030)
 Figure 67. Japan Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 68. South Korea Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 69. China Taiwan Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 70. Southeast Asia Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 71. India Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 72. Australia Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 73. Middle East, Africa and Latin America Diabetes Medicines Sales Market Share by Type (2019-2030)
 Figure 74. Middle East, Africa and Latin America Diabetes Medicines Revenue Market Share by Type (2019-2030)
 Figure 75. Middle East, Africa and Latin America Diabetes Medicines Sales Market Share by Application (2019-2030)
 Figure 76. Middle East, Africa and Latin America Diabetes Medicines Revenue Market Share by Application (2019-2030)
 Figure 77. Middle East, Africa and Latin America Diabetes Medicines Revenue Share by Country (2019-2030)
 Figure 78. Middle East, Africa and Latin America Diabetes Medicines Sales Share by Country (2019-2030)
 Figure 79. Brazil Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 80. Mexico Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 81. Turkey Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 82. Israel Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 83. GCC Countries Diabetes Medicines Revenue (2019-2030) & (US$ Million)
 Figure 84. Diabetes Medicines Value Chain
 Figure 85. Diabetes Medicines Production Process
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global Diabetes Medicines market is projected to grow from US$ 109380 million in 2024 to US$ 207020 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period.

Descriptive company profiles of the major global players, including Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

Market Segmentation